Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

341
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
341
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Deep learning models for predicting opaque bubble layer morphology of keratorefractive lenticule extraction before laser scanning.

Advances in ophthalmology practice and research·2026
Same author

CeO<sub>2</sub>@CA@PEI@dextran improves drug sensitivity in chronic myelogenous Leukemia through scavenging free radical efficiently.

Journal of colloid and interface science·2026
Same author

A Conversation Aid for Climate Conscious Inhaler Prescribing.

Chest·2026
Same author

Regulating the Adsorbed Hydrogen Coverage for a Good Trade-Off between Hydrogen Evolution Activity and Electrochemiluminescence Performance.

Analytical chemistry·2026
Same author

Combined exposure to microplastics and PFASs on earthworms: size and concentration effects.

Environmental geochemistry and health·2026
Same author

Inclusive climate perception and voice behavior among new generation employees in China: the role of workplace friendship and relational attribution.

Frontiers in psychology·2026
Same journal

A qualitative study of the impact of the COVID-19 pandemic on healthcare access and service delivery for people living with chronic obstructive pulmonary disease and asthma.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Preventive effect of heat-killed Lactiplantibacillus plantarum FM8 in an ovalbumin-induced food allergy murine model.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Mepolizumab reduces healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps: a linked EMR and claims-based pre-post study.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Triggers, clinical spectra and outcomes of pediatric anaphylaxis in a tertiary center: impact of comorbidities and cofactors on severity.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Declining venom immunotherapy: patient characteristics and clinical outcomes.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Longitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
查看所有相关文章

相关实验视频

Updated: May 28, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K

喘 喘 是一种

Andrew O'Keefe1, Lori Connors2, Ling Ling3

  • 1Memorial University, St. John's, NF, Canada. okeefe@nlallergy.ca.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
|February 10, 2025
PubMed
概括
此摘要是机器生成的。

许多加拿大人控制不良的喘,但有效的治疗方法,如吸入皮质类固醇和生物药物可以帮助. 适当的诊断,患者教育和管理并发症对于所有年龄段的最佳喘控制至关重要.

更多相关视频

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.1K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

5.9K

相关实验视频

Last Updated: May 28, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.1K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

5.9K

科学领域:

  • 呼吸系统医学 呼吸系统医学
  • 过敏和免疫学 过敏和免疫学

背景情况:

  • 喘是加拿大普遍存在的呼吸系统疾病,很大一部分患者经历了低于最佳的疾病控制.
  • 目前的治疗选择包括吸入性皮质类固醇 (ICS),ICS/长效β2-激动剂 (LABA),三重疗法 (ICS/LABA/长效肌受体对抗剂) 和生物药物.

研究的目的:

  • 审查当前关于成人和儿童喘诊断和管理的文献和指导方针.
  • 突出严重喘治疗的进展,特别是生物疗法的作用.
  • 强调除药物治疗之外的综合性喘管理策略.

主要方法:

  • 审查当前的科学文献.
  • 对喘诊断和管理的既定临床指南的分析.
  • 专注于基于证据的治疗方法和基本的管理组件.

主要成果:

  • 适当的药物治疗,包括ICS,ICS/LABA,三重疗法和生物药物,可以在大多数患者中实现喘控制.
  • 生物疗法在严重喘的医疗管理方面取得了重大进展.
  • 过敏原特异性免疫疗法为精选的喘患者提供了潜在的疾病修饰.
  • 综合管理包括定期监测,患者教育,行动计划,解决坚持障碍,管理伴随性疾病和技术审查.

结论:

  • 有效的喘管理需要采用多方面的方法,将适当的药物治疗与以患者为中心的策略相结合.
  • 严重喘治疗的景观已经被生物疗法所改变.
  • 医生的专业知识对于特定的治疗,如过敏原特异性免疫疗法至关重要.